The prevalence of chronic diseases has led to the need for faster diagnostic tools. Flow cytometry is a technology that relies on laser and electric impedance for diagnosis and determination of the nature of cell samples. Instruments such as cell sorters, cell analyzers, and biomarkers are used to determine multiple parameters of individual cells. They can be used to expedite the diagnostic process of assays.
Need For Flow Cytometry
A flow cytometer allows the addition of fluorescent probes to the cells to make cell counting easier. It can be used to determine the number of chromosomes per cell in biopsy specimens. This instrument uses fluorochromes to target protein stains of interest in the cells. The photomultiplying tubes within cytometers are programmed to detect the scattering of light at a certain wavelength and match it with excitation levels of cells. They are used to distinguish stained cells from non-stained cells.
Technological Advancements to Aid Immunology
The advent of lab-on-a-chip (LOC) has triggered the development of flow cytometers and their repository of instruments and accessories. It has made it possible to conduct faster and accurate assays of cell samples.
Beckman Coulter, one of the biggest manufacturers of life sciences equipment, has launched a new cytometer with options for additional excitation sources in the visible light spectrum. The product, CytoFLEX LX, is compatible with different lasers to detect the light emitted after excitation. This can open up new avenues for testing cell interactions under regular and irregular conditions.
The BD LSRFortessa X-20, a flow cytometer from BD Life Sciences, is a device that can execute multicolor analysis of cells and with the ability to detect nearly 20 parameters concurrently. It has been used in immunophenotyping experiments at Trinity College in Dublin to identify biomarkers successfully. The device is being used to study the immune system in schizophrenic patients.
Market Overview
The flow cytometry instruments market in the United States is expected to gain a windfall by 2022, according to a report on Radiant Insights, Inc. It is driven by the need for faster and accurate assays to diagnose chronic diseases. The market is projected to grow at a considerable CAGR during the forecast period (2016 to 2022).
Product-wise, the market is bifurcated into cell sorters and analyzers. Cell sorters may gain prominence in near future due to development of advanced techniques used in HIV/AIDS diagnosis. Clinical applications may grow robustly over the forecast period due to demand for tools with a high workflow rate. Key market players include Beckman Coulter Inc.; Thermo Fisher Scientific; Merck KGaA; and BD Life Sciences.
A flow cytometer allows the addition of fluorescent probes to the cells to make cell counting easier. It can be used to determine the number of chromosomes per cell in biopsy specimens. This instrument uses fluorochromes to target protein stains of interest in the cells. The photomultiplying tubes within cytometers are programmed to detect the scattering of light at a certain wavelength and match it with excitation levels of cells. They are used to distinguish stained cells from non-stained cells.
Technological Advancements to Aid Immunology
The advent of lab-on-a-chip (LOC) has triggered the development of flow cytometers and their repository of instruments and accessories. It has made it possible to conduct faster and accurate assays of cell samples.
Beckman Coulter, one of the biggest manufacturers of life sciences equipment, has launched a new cytometer with options for additional excitation sources in the visible light spectrum. The product, CytoFLEX LX, is compatible with different lasers to detect the light emitted after excitation. This can open up new avenues for testing cell interactions under regular and irregular conditions.
The BD LSRFortessa X-20, a flow cytometer from BD Life Sciences, is a device that can execute multicolor analysis of cells and with the ability to detect nearly 20 parameters concurrently. It has been used in immunophenotyping experiments at Trinity College in Dublin to identify biomarkers successfully. The device is being used to study the immune system in schizophrenic patients.
Market Overview
The flow cytometry instruments market in the United States is expected to gain a windfall by 2022, according to a report on Radiant Insights, Inc. It is driven by the need for faster and accurate assays to diagnose chronic diseases. The market is projected to grow at a considerable CAGR during the forecast period (2016 to 2022).
Product-wise, the market is bifurcated into cell sorters and analyzers. Cell sorters may gain prominence in near future due to development of advanced techniques used in HIV/AIDS diagnosis. Clinical applications may grow robustly over the forecast period due to demand for tools with a high workflow rate. Key market players include Beckman Coulter Inc.; Thermo Fisher Scientific; Merck KGaA; and BD Life Sciences.
Request free sample at:
No comments:
Post a Comment